Efavirenz (Sustiva) receives FDA approval. Food and Drug Administration.  [electronic resource] 

 -  Project Inform perspective  Dec 1998 
 - 11 p.  digital 
<br/><br/> Publication Type: Newspaper Article; Journal Article 
<br/><br/><label>ISSN: </label>1058-7454 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alkynes<br/>Benzoxazines<br/>Child<br/>Child, Preschool<br/>Cyclopropanes<br/>Drug Approval<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Drugs, Investigational<br/>HIV Infections--drug therapy<br/>Health Services Accessibility<br/>Humans<br/>Oxazines--adverse effects<br/>Reverse Transcriptase Inhibitors--adverse effects<br/>United States Food and Drug Administration